A GLIM-defined malnutrition-based model for predicting prognosis of cirrhotic patients with portal hypertension following TIPS procedure
- PMID: 40813957
- PMCID: PMC12355858
- DOI: 10.1186/s12876-025-04160-y
A GLIM-defined malnutrition-based model for predicting prognosis of cirrhotic patients with portal hypertension following TIPS procedure
Abstract
Background & Aims: Malnutrition detrimentally impacts the prognosis of patients with cirrhotic portal hypertension (CPH). This study aimed to determine the prevalence of malnutrition using the Global Leadership Initiative on Malnutrition (GLIM) criteria, and its effect on post-transjugular intrahepatic portosystemic shunt (TIPS) hepatic encephalopathy (HE) occurrence and mortality in patients with CPH.
Methods: This study incorporated 330 CPH patients who underwent TIPS between December 2015 and March 2022. Employing the GLIM criteria, patients were categorized into normal nutrition, moderate, and severe malnutrition groups. The incidence of HE and survival rates were compared among these groups. A survival prediction nomogram was constructed using individual predictive factors from the GLIM criteria.
Results: A total of 170 (51.52%) patients were diagnosed with malnutrition [moderate (n = 130) and severe (n = 40)]. Malnutrition correlated with an increased incidence of post-TIPS overt (p < 0.001) and severe HE (p = 0.003) and diminished overall survival (OS) rates (p < 0.0001). Malnutrition based on GLIM criteria was the independent predictor for HE and post-TIPS survival (HR = 1.64, 95%CI: 1.27–2.13, p < 0.001 and HR = 2.13, 95%CI: 1.53–2.96, p < 0.001, respectively). The nomogram, integrating factors including age, ascites, low calibrated body mass index (BMIc), and sarcopenia, demonstrated strong predictive capabilities for post-TIPS survival rates both in the training set (C-index, 0.755, 95%CI: 0.684–0.826) and validation set (C-index, 0.767, 95%CI: 0.613–0.921).
Conclusions: The GLIM-based diagnosis of malnutrition in patients with CPH independently predicts the risk of post-TIPS HE and mortality. The constructed nomogram exhibits a commendable predictive efficacy for post-TIPS survival.
Supplementary Information: The online version contains supplementary material available at 10.1186/s12876-025-04160-y.
Keywords: Cirrhotic portal hypertension; GLIM criteria; Hepatic encephalopathy; Malnutrition; Survival; Transjugular intrahepatic portosystemic shunt.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was conducted with strict adherence to the Declaration of Helsinki. This study was approved by the Ethics Review Committee of the First Affiliated Hospital of the University of Science and Technology of China(approval number: 2023-RE-283). The need for informed consent was waived by the Ethics Review Committee due to the retrospective nature of this study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures



Similar articles
-
Sarcopenia is a risk factor for post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy and mortality: A systematic review and meta-analysis.Indian J Gastroenterol. 2024 Aug;43(4):748-759. doi: 10.1007/s12664-023-01465-2. Epub 2023 Dec 12. Indian J Gastroenterol. 2024. PMID: 38085501
-
Case Report: transjugular intrahepatic portosystemic shunt combined with hemodialysis for refractory ascites treatment in a patient with idiopathic non-cirrhotic portal hypertension and uremia.Front Med (Lausanne). 2025 Jul 18;12:1607521. doi: 10.3389/fmed.2025.1607521. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40757205 Free PMC article.
-
Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.Cochrane Database Syst Rev. 2018 Oct 31;10(10):CD001023. doi: 10.1002/14651858.CD001023.pub3. Cochrane Database Syst Rev. 2018. PMID: 30378107 Free PMC article.
-
Identifying the optimal measurement timing and hemodynamic targets of portal pressure gradient after TIPS in patients with cirrhosis and variceal bleeding.J Hepatol. 2025 Feb;82(2):245-257. doi: 10.1016/j.jhep.2024.08.007. Epub 2024 Aug 22. J Hepatol. 2025. PMID: 39181214
-
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review.Nutrients. 2023 Mar 27;15(7):1617. doi: 10.3390/nu15071617. Nutrients. 2023. PMID: 37049459 Free PMC article.
References
-
- Maharshi S, Sharma BC, Srivastava S. Malnutrition in cirrhosis increases morbidity and mortality. J Gastroenterol Hepatol. 2015;30(10):1507–13. - PubMed
-
- Ruiz-Margáin A, Macías-Rodríguez RU, Ampuero J, Cubero FJ, Chi-Cervera L, Ríos-Torres SL, Duarte-Rojo A, Espinosa-Cuevas Á, Romero-Gómez M, Torre A. Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis. World J Gastroenterol. 2016;22(45):10064–70. - PMC - PubMed
-
- Holster IL, Tjwa ETTL, Moelker A, Wils A, Hansen BE, Vermeijden JR, Scholten P, van Hoek B, Nicolai JJ, Kuipers EJ, et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding. Hepatology. 2016;63(2):581–9. - PubMed
-
- Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology (Baltimore, MD). 2014;60(2):715–35. - PubMed
-
- Tandon P, Raman M, Mourtzakis M, Merli M. A practical approach to nutritional screening and assessment in cirrhosis. Hepatology. 2017;65(3):1044–57. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials